Sirtex Medical Ltd. | |
Stock Exchange | Other OTC |
EPS |
$0.57 |
Market Cap |
$1.31 B |
Shares Outstanding |
55.78 M |
Public Float |
- |
Sirtex Medical Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.73 |
Market Cap |
AUD1.85 B |
Shares Outstanding |
55.79 M |
Public Float |
49.96 M |
Address |
101 Miller Street North Sydney New South Wales (NSW) 2060 Australia |
Employees | - |
Website | http://www.sirtex.com |
Updated | 09/14/2018 |
Sirtex Medical Ltd. engages in the research, commercial development, manufacture, and distribution of liver cancer treatments. It offers targeted radiation therapy known as SIR-Spheres Y-90 resin microspheres. Its clinical programs include SIRFLOX, FOXFIRE/FOXFIRE Global, SARAH, SIRveNIB, and SORAMIC. |